Astrana Health Price to Sales Ratio 2016-2025 | ASTH
Historical PS ratio values for Astrana Health (ASTH) over the last 10 years. The current P/S ratio for Astrana Health as of April 17, 2026 is .
| Astrana Health P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-04-17 | 31.50 | 0.49 | |
| 2025-12-31 | 24.81 | $64.51 | 0.38 |
| 2025-09-30 | 28.35 | $59.13 | 0.48 |
| 2025-06-30 | 24.88 | $49.73 | 0.50 |
| 2025-03-31 | 31.01 | $46.63 | 0.67 |
| 2024-12-31 | 31.53 | $42.41 | 0.74 |
| 2024-09-30 | 57.94 | $36.06 | 1.61 |
| 2024-06-30 | 40.56 | $33.55 | 1.21 |
| 2024-03-31 | 41.99 | $30.86 | 1.36 |
| 2023-12-31 | 38.30 | $29.57 | 1.30 |
| 2023-09-30 | 30.85 | $28.50 | 1.08 |
| 2023-06-30 | 31.60 | $27.95 | 1.13 |
| 2023-03-31 | 36.47 | $26.36 | 1.38 |
| 2022-12-31 | 29.59 | $24.90 | 1.19 |
| 2022-09-30 | 39.00 | $22.75 | 1.71 |
| 2022-06-30 | 38.59 | $20.79 | 1.86 |
| 2022-03-31 | 48.47 | $18.76 | 2.58 |
| 2021-12-31 | 73.48 | $17.08 | 4.30 |
| 2021-09-30 | 91.05 | $17.50 | 5.20 |
| 2021-06-30 | 62.81 | $17.39 | 3.61 |
| 2021-03-31 | 27.09 | $17.99 | 1.51 |
| 2020-12-31 | 18.27 | $18.36 | 1.00 |
| 2020-09-30 | 17.94 | $18.55 | 0.97 |
| 2020-06-30 | 16.50 | $17.88 | 0.92 |
| 2020-03-31 | 12.92 | $16.88 | 0.77 |
| 2019-12-31 | 18.41 | $14.98 | 1.23 |
| 2019-09-30 | 17.62 | $12.88 | 1.37 |
| 2019-06-30 | 16.71 | $13.10 | 1.28 |
| 2019-03-31 | 18.32 | $12.91 | 1.42 |
| 2018-12-31 | 19.85 | $13.65 | 1.45 |
| 2018-09-30 | 22.07 | $15.04 | 1.47 |
| 2018-06-30 | 25.86 | $14.12 | 1.83 |
| 2018-03-31 | 15.95 | $13.74 | 1.16 |
| 2017-12-31 | 24.00 | $13.48 | 1.78 |
| 2017-09-30 | 9.75 | $9.28 | 1.05 |
| 2017-06-30 | 10.00 | $5.86 | 1.71 |
| 2017-03-31 | 9.00 | $3.00 | 3.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.536B | $3.182B |
| Astrana Health is a provider-centric, technology-powered healthcare company. It operates an integrated healthcare delivery platform which enables providers to participate in value-based care arrangements. Astrana Health, formerly known as Apollo Medical Holdings Inc., is based in ALHAMBRA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |